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Conclusions: In this study we demonstrate that adipokine levels are
signiﬁcantly increased in end-stage knee OA patients considered for joint
replacement surgery when compared to a healthy control group. We also
demonstrate a clear relation of these adipokines with age and with BMI
and a clear difference between men and women. Most interestingly,
these serum (peripheral) adipokines correlated with local parameters of
inﬂammation of the OA joints. It is concluded that systemically measured
adipokines play a role in the OA disease process also locally at the joint
level.
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CARTILAGE IS NOT THE FIRST KNEE TISSUE TO DEGENERATE IN
ASSOCIATION WITH FEMALE HORMONAL ASPECTS
B.M. de Klerk, D. Schiphof, E.H. Oei, H. Weinans, A. Hofman, B. Koes,
S.M. Bierma-Zeinstra. Erasmus Univ. Med. Ctr., Rotterdam, Netherlands
Purpose: Osteoarthritis (OA) affects all joint tissues and currently it is not
known which tissue is actually affected ﬁrst. When studying prevalent
OA cases with radiography it is impossible to distinguish where in the
joint the degeneration of tissues started. Magnetic resonance imaging
(MRI) can visualize degeneration of individual tissues in an earlier stage
than radiography.
The development of OA can be inﬂuenced by high body weight in
various manners. Not only locally by higher biomechanical loading
of the knees, but also systemically by secretion of inﬂammatory
mediators and hormones. Hormonal levels change around the time of
menopause, concurrently with an increased incidence of OA in women.
This simultaneous occurrence of menopause and increased OA incidence
suggests a role for female hormones, which has been suggested for a long
time, but the exact underlying mechanism has not yet been elucidated.
To gain insight into where degeneration of joint tissues starts in relation
to female hormonal aspects, we studied cross-sectional associations of
female hormonal determinants with the prevalence of early degenerative
signs in knee tissues on MRI.
Methods: Data of the RS-III-1 cohort of the Rotterdam study (a
population based cohort study) was used. Eligible participants for the
present study were females aged 45–60 years who had no OA in both
knees (Kellgren and Lawrence grade 0 or 1 on radiography) and for
whom knee MRI data was available. The effect of risk factors may differ
according to BMI, therefore we subdivided women according to BMI
category: women with high BMI (≥27) and women with low/normal BMI
(<27). In total 466 women with normal BMI (mean age 53.5 (SD 3.69),
932 knees) and 357 women with high BMI (mean age 53.8 (SD 3.97),
714 knees) were included.
General Estimating Equations analysis was used, with ‘knee side’
as within-subject variable, to test the associations between female
hormonal aspects and degenerative signs of knee tissues. The hormonal
aspects tested were: natural menopause (PostMP), age at menarche,
current use of hormone replacement therapy (HRT) and years since
menopause (YSM). Tissues assessed for degenerative signs were:
meniscus, cartilage, and bone (osteophytes and bone marrow lesions
(BMLs)). In addition, joint effusion was studied.
Results: Of the included knees 17.8% had a KL-grade 1 in the high BMI
group and 13.0% in the low/normal BMI group. In overweight women we
found that being PostMP was signiﬁcantly associated with the presence
of osteophytes in the tibiofemoral joint (OR=2.31 (1.12–4.83) and YSM
with presence of BMLs (OR=1.05 (1.01–1.09)), but both associations were
not observed in normal weight women (PostMP-osteophytes: OR=0.98
(0.53–1.79), YSM-BML: OR=0.98 (0.95–1.01)). Having an early menarche
(<12 years old) was protective for degeneration of the lateral meniscus
in overweight women only (OR=0.39 (0.20–0.77). Current use of HRT
seemed to be signiﬁcantly protective for joint effusion in overweight
women only (OR=0.18 (0.04–0.72). We did not ﬁnd any signiﬁcant
associations with cartilage degeneration.
Conclusions: We found indications that early signs of degeneration of
knee tissues, in relation with female hormonal aspects, may start in the
bone (bone marrow lesions and osteophytes), but not in cartilage.
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ADIPOSE STROMAL CELLS DOWN-MODULATE INFLAMMATORY
FACTORS IN SYNOVIOCYTES AND CHONDROCYTES FROM
OSTEOARTHRITIS PATIENTS
C. Manferdini1, A. Piacentini1, M. Maumus2, E. Gabusi1, J-A. Peyraﬁtte3,
C. Jorgensen2, A. Facchini1, D. Noel2, G. Lisignoli1. 1Istituto Ortopedico
Rizzoli, IOR, Bologna, Italy; 2Inserm, Montpellier, France; 3EFS-PM, Toulose,
France
Purpose: Osteoarthritis (OA) is a degenerative disease of the articular
joint that causes a degeneration of cartilage and for which no efﬁcient
treatments are available. It has been shown that adipose stromal cells
(ASC) have anti-ﬁbrotic, anti-inﬂammatory and anti-apoptotic properties,
through secreted growth factors, therefore can be good candidates for
preventing the evolution of OA disease. Therefore, the aim of the study
was the analysis of trophic potential effects of ASC on synoviocytes and
chondrocytes from OA patients.
Methods: ASC were isolated from intra-articular (Hoffa-ASC) or hip
(hip-ASC) subcutaneous adipose tissue of OA patients. Synoviocytes
and chondrocytes were isolated from synovium and cartilage of OA
patients undergoing total joint replacement. ASC were seeded in a
transwell and co-incubated with synoviocytes or chondrocytes grown
in monolayer for 7 days. Speciﬁc markers of inﬂammation (IL1b, IL6, IL8
and TNFa) were tested by RT-qPCR analysis and secreted factors (IL6,
IL17, CXCL8/IL8, CCL2/MCP-1, CCL3/MIP-1a, CCL5/RANTES,) by multiplex
bead-based sandwich immunoassay.
Results: Synoviocytes expressed higher basal levels of mRNA for IL1b,
IL6, IL8 and TNFa than chondrocytes. Both Hoffa-ASC or hip-ASC were
able to down-modulate the expression of IL1b, IL6, IL8 on synoviocytes
while only the expression of IL1b and IL6 were signiﬁcantly reduced
on chondrocytes. IL1b and TNFa were not secreted while IL6, IL8, IL17,
MCP-1, MIP-1a, RANTES were highly produced by both synoviocytes and
chondrocytes. Chondrocytes secreted approximately three times more
IL6, IL8 and MCP-1 than synoviocytes, while MIP1a was secreted eight
fold more than chondrocytes and no differences were measured for IL17
and RANTES. Hoffa-ASC alone produced higher level of RANTES and
IL17 than hip-ASC, however both ASC types signiﬁcantly decreased IL6,
IL8, IL17, MCP-1, MIP-1a, RANTES secretion of both chondrocytes and
synoviocytes.
Conclusions: These data demonstrate that ASC even if derived from
two different sources were able to produce trophic factors that exert
anti-inﬂammatory effects on both synoviocytes and chondrocytes so
corroborating their potential use in preventing OA evolution.
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THE EFFECT OF BARIATRIC SURGERY ON THE RESOLUTION AND
SEVERITY OF OSTEOARTHRITIS AND OTHER OBESITY-RELATED
COMORBIDITIES
J.X. Liu, J.K. Saunders, M. Parikh, S.B. Abramson. NYU Hosp. for Joint
Diseases, New York, NY, USA
Purpose: The purpose of this study was to objectively assess the
resolution ofosteoarthritis and other obesity-related comorbidities (ORC)
after bariatric surgery and to compare the status and resolution
ofosteoarthritis and other ORCs following laparoscopic adjustable
gastric banding (LAGB), roux-en-Y gastric bypass (RYGB), and sleeve
gastrectomy (LSG).
Methods: Data was collected from an IRB-approved electronic registry,
including patient demographics, weight, BMI, and ORC status. Using the
registry, osteoarthritis, as well as nine other ORCs were scored, pre-op
and post-op, from 0–5 according to severity using the Assessment of
Obesity-Related Comorbidities (AORC) Scale, the basis for the Bariatric
Outcomes Longitudinal Database. The ten ORCs were: osteoarthritis (OA),
diabetes, hypertension (HTN), obstructive sleep apnea, hyperlipidemia
(HLD), gastroesophageal reﬂux disease (GERD), depression, urinary stress
incontinence, hernia, and lower extremity edema (LEE). Resolution
of disease was deﬁned as having AORC > 0 pre-surgery and AORC=0
post-surgery. Change in ORC status was calculated with the following
equation: (pre-op AORC score) − (post-op AORC score). Paired t-tests were
utilized to determine whether comorbidity score change was signiﬁcant
following bariatric surgery. Fisher’s exact tests were used to determine if
there was a signiﬁcant difference in ORC resolution between procedures.
Results: 264 patients with ORC underwent bariatric surgery between
January 2008 and March 2010 at an urban safety-net hospital. Average
pre-op age was 42.5, and average pre-op BMI was 44.2. At mean patient
